Acetazolamide (extended-release capsule): Difference between revisions
m Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | |||
{{CMG}} | {{Acetazolamide}} | ||
{{CMG}}; {{AE}} {{SS}} | |||
'''''For patient information about Acetazolamide, click [[Acetazolamide (patient information)|here]].''''' | |||
{{SB}} DIAMOX SEQUELS<sup>®</sup> | |||
==Overview== | |||
'''Acetazolamide''', sold under the trade name '''Diamox''', is a [[carbonic anhydrase]] inhibitor that is used to treat [[glaucoma]], [[epileptic seizure]]s, [[benign intracranial hypertension]], [[altitude sickness]], [[cystinuria]], and dural ectasia. Acetazolamide is available as a [[generic drug]] and is also used as a [[diuretic]]. | '''Acetazolamide''', sold under the trade name '''Diamox''', is a [[carbonic anhydrase]] inhibitor that is used to treat [[glaucoma]], [[epileptic seizure]]s, [[benign intracranial hypertension]], [[altitude sickness]], [[cystinuria]], and dural ectasia. Acetazolamide is available as a [[generic drug]] and is also used as a [[diuretic]]. | ||
==Category== | |||
Carbonic anhydrase inhibitors;Mountaineering and health;Anticonvulsants;Sulfonamides;World Health Organization essential | |||
medicines;Thiadiazoles;Amides;Cardiovascular Drugs | |||
== | ==FDA Package Insert== | ||
====DIAMOX SEQUELS (acetazolamide) capsule, extended release==== | |||
''' [[Acetazolamide indications and usage|Indications and Usage]]''' | |||
'''| [[Acetazolamide dosage and administration|Dosage and Administration]]''' | |||
'''| [[Acetazolamide dosage forms and strengths|Dosage Forms and Strengths]]''' | |||
'''| [[Acetazolamide contraindications|Contraindications]]''' | |||
'''| [[Acetazolamide warnings and precautions|Warnings and Precautions]]''' | |||
'''| [[Acetazolamide adverse reactions|Adverse Reactions]]''' | |||
'''| [[Acetazolamide drug interactions|Drug Interactions]]''' | |||
'''| [[Acetazolamide use in specific populations|Use in Specific Populations]]''' | |||
'''| [[Acetazolamide overdosage|Overdosage]]''' | |||
'''| [[Acetazolamide description|Description]]''' | |||
'''| [[Acetazolamide clinical pharmacology|Clinical Pharmacology]]''' | |||
'''| [[Acetazolamide nonclinical toxicology|Nonclinical Toxicology]]''' | |||
'''| [[Acetazolamide clinical studies|Clinical Studies]]''' | |||
'''| [[Acetazolamide how supplied storage and handling|How Supplied/Storage and Handling]]''' | |||
'''| [[Acetazolamide patient counseling information|Patient Counseling Information]]''' | |||
'''| [[Acetazolamide labels and packages|Labels and Packages]]''' | |||
==Mechanism of Action== | |||
Acetazolamide is a [[carbonic anhydrase inhibitor]]. It can be used for the medical treatment of moderate to severe metabolic or respiratory alkalosis. Acetazolamide does this by interfering with [[bicarbonate]] (HCO<sub>3</sub><sup>-</sup>) reabsorption in the [[kidney]]s, thereby reacidifying the blood – hence [[alkali|alkalyzing]] the urine. | |||
[[Carbonic anhydrase]] (CA) catalyzes the first part of the following [[reversible reaction]] in which carbon dioxide (CO<sub>2</sub>) and water (H<sub>2</sub>O) are converted to carbonic acid (H<sub>2</sub>CO<sub>3</sub>) and vice-versa (the second half happens spontaneously, favouring production of H<sup>+</sup> + HCO<sub>3</sub><sup>-</sup>): | |||
CO<sub>2</sub> + H<sub>2</sub>O <--<sup>CA</sup>--> H<sub>2</sub>CO<sub>3</sub> <--> H<sup>+</sup> + HCO<sub>3</sub><sup>-</sup> | |||
In the kidney tubules, locally secreted hydrogen ions normally combine with [[Renal_physiology#Filtration|filtered]] bicarbonate (HCO<sub>3</sub><sup>-</sup>) to form carbonic acid (H<sub>2</sub>CO<sub>3</sub>). Carbonic acid in turn is normally acted upon by carbonic anhydrase, leading to formation of CO<sub>2</sub>. As CO<sub>2</sub> rapidly leaves the tubules by diffusing across cell membranes, the above reaction normally runs shifted strongly to the left (i.e. reversed), and more bicarbonate can be continuously reabsorbed from the preurine. However, in the presence of acetazolamide, carbonic anhydrase is inhibited and carbonic acid levels build up. The inhibition of carbonic anhydrase in turn leads to a slowing of the reverse reaction and a decrease in the body's ability to reabsorb serum bicarbonate, resulting in urinary bicarbonate wasting. This leads to a decreased ability to exchange Na<sup>+</sup> for H<sup>+</sup> in the presence of acetazolamide (in proximal convoluted tubules of kidney) resulting in a mild diuresis.<ref>Lippincott's Illustrated Reviews: Pharmacology, 4th edition page 428</ref> By contrast, the H<sup>+</sup> that is also present in the lumen is reabsorbed via an alternative pathway along with Cl<sup>-</sup>; it then passes into the bloodstream, leading to hyperchloremic metabolic acidosis.<ref>Renal and Electrolyte Disorders Schrier 1976: page 89</ref> This effect can also be used for therapeutic correction of alkalosis seen in altitude sickness or other forms of [[respiratory alkalosis]]. | |||
==References== | ==References== | ||
{{reflist|2}} | |||
{{Anticonvulsants}} | |||
{{Antiglaucoma preparations and miotics}} | |||
{{Diuretics}} | |||
[[Category:Carbonic anhydrase inhibitors]] | [[Category:Carbonic anhydrase inhibitors]] | ||
[[Category:Mountaineering]] | [[Category:Mountaineering and health]] | ||
[[Category:Anticonvulsants]] | [[Category:Anticonvulsants]] | ||
[[Category:Sulfonamides]] | [[Category:Sulfonamides]] | ||
[[Category:World Health Organization essential medicines]] | |||
[[Category:Thiadiazoles]] | |||
[[Category:Amides]] | |||
[[ | [[Category:Cardiovascular Drugs]] | ||
[[ | [[Category:Drugs]] | ||
[[ | |||
[[ | |||
Revision as of 21:02, 25 February 2014
Acetazolamide |
---|
DIAMOX SEQUELS® FDA Package Insert |
Indications and Usage |
Dosage and Administration |
Contraindications |
Warnings and Precautions |
Adverse Reactions |
Drug Interactions |
Use in Specific Populations |
Overdosage |
Description |
Clinical Pharmacology |
Nonclinical Toxicology |
How Supplied/Storage and Handling |
Labels and Packages |
Clinical Trials on Acetazolamide |
ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
For patient information about Acetazolamide, click here. Synonyms / Brand Names: DIAMOX SEQUELS®
Overview
Acetazolamide, sold under the trade name Diamox, is a carbonic anhydrase inhibitor that is used to treat glaucoma, epileptic seizures, benign intracranial hypertension, altitude sickness, cystinuria, and dural ectasia. Acetazolamide is available as a generic drug and is also used as a diuretic.
Category
Carbonic anhydrase inhibitors;Mountaineering and health;Anticonvulsants;Sulfonamides;World Health Organization essential medicines;Thiadiazoles;Amides;Cardiovascular Drugs
FDA Package Insert
DIAMOX SEQUELS (acetazolamide) capsule, extended release
Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages
Mechanism of Action
Acetazolamide is a carbonic anhydrase inhibitor. It can be used for the medical treatment of moderate to severe metabolic or respiratory alkalosis. Acetazolamide does this by interfering with bicarbonate (HCO3-) reabsorption in the kidneys, thereby reacidifying the blood – hence alkalyzing the urine.
Carbonic anhydrase (CA) catalyzes the first part of the following reversible reaction in which carbon dioxide (CO2) and water (H2O) are converted to carbonic acid (H2CO3) and vice-versa (the second half happens spontaneously, favouring production of H+ + HCO3-):
CO2 + H2O <--CA--> H2CO3 <--> H+ + HCO3-
In the kidney tubules, locally secreted hydrogen ions normally combine with filtered bicarbonate (HCO3-) to form carbonic acid (H2CO3). Carbonic acid in turn is normally acted upon by carbonic anhydrase, leading to formation of CO2. As CO2 rapidly leaves the tubules by diffusing across cell membranes, the above reaction normally runs shifted strongly to the left (i.e. reversed), and more bicarbonate can be continuously reabsorbed from the preurine. However, in the presence of acetazolamide, carbonic anhydrase is inhibited and carbonic acid levels build up. The inhibition of carbonic anhydrase in turn leads to a slowing of the reverse reaction and a decrease in the body's ability to reabsorb serum bicarbonate, resulting in urinary bicarbonate wasting. This leads to a decreased ability to exchange Na+ for H+ in the presence of acetazolamide (in proximal convoluted tubules of kidney) resulting in a mild diuresis.[1] By contrast, the H+ that is also present in the lumen is reabsorbed via an alternative pathway along with Cl-; it then passes into the bloodstream, leading to hyperchloremic metabolic acidosis.[2] This effect can also be used for therapeutic correction of alkalosis seen in altitude sickness or other forms of respiratory alkalosis.
References
Template:Anticonvulsants Template:Antiglaucoma preparations and miotics Template:Diuretics